Back

Potential use of PCSK9 inhibitors in secondary prevention for patients with treated acute coronary syndrome. A study from a large UK university teaching hospital

6 April 2017 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session I - Thursday 08:30 - 18:00 - Diabetes/ Lipids/Obesity/Nutrition_Part 2 Lipids EAPC Premium Access EuroPrevent 2017

About the speaker

Photo
Doctor Ahmed Farouk Mohamed Elamin

Liverpool Heart and Chest Hospital, Liverpool (United Kingdom of Great Britain & Northern Ireland)

8 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor J. Daigle (Halifax, CA)
Presentation thumbnail
Doctor A. Chauca Tapia (Barcelona, ES)
Abstract
Presentation thumbnail
Doctor K. Mzoughi (Bizerta, TN)
Abstract
Presentation thumbnail
Associate Professor D. Platonov (Tver, RU)

Access the full session

Session thumbnail
Poster Session I - Thursday 08:30 - 18:00 - Diabetes/ Lipids/Obesity/Nutrition_Part 2

The Event

Event poster

EuroPrevent 2017

6 April 2017 08:30 CET